Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort - 19/06/24
Doi : 10.1016/j.jaad.2024.03.029
Yanmei Peng, MD, PhD a, b, Ashok V. Kumar, MS a, Zhong Gu, MS a, Nikhila Kosuru, BS a, Jason A. Wampfler, BS c, Pedro A. Reck dos Santos, MD d, Nathan Y. Yu, MD e, Jonathan D'Cunha, MD, PhD d, Vinicius Ernani, MD f, Collin M. Costello, MD g, Ping Yang, MD, PhD a, ⁎ 
a Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona
b Department of Oncology, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China
c Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota
d Division of Thoracic Surgery, Mayo Clinic, Scottsdale, Arizona
e Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona
f Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona
g Department of Dermatology, Mayo Clinic, Scottsdale, Arizona
∗Correspondence to: Ping Yang, MD, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259Division of EpidemiologyDepartment of Quantitative Health SciencesMayo Clinic13400 E Shea BlvdScottsdaleAZ85259
Key words : dermatologic toxicity, immunotherapy, lung cancer, survival, targeted therapy
| Funding sources: This study was supported by the National Institutes of Health [Grant Numbers R03 CA77118, R01 CA80127 and R01 CA84354]; the National Institute on Aging [Grant Numbers R01 AG034676 and R01 AG052425]; the Mayo Clinic Foundation. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by the Mayo Foundation Institutional Review Board (IRB# 225-9). |
© 2024
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 91 - N° 1
P. 172-175 - luglio 2024 Ritorno al numero
Articolo precedente
- Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
- James P. Pham, Nana A.L. Rosenø, Gabriele Roccuzzo, Ryan C. Saal, Alexander Egeberg, Hans C. Ring, John W. Frew
- Retrospective review of Mpox: Morphology and presentation in skin of color and sexual minorities
- Richard W. Kim, Ning C. McKenzie, Kieron S. Leslie
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?